These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9722882)

  • 1. Reduced infectivity of human immunodeficiency virus type 1 produced in the presence of a truncated Gag protein containing p7 gag and p6 gag.
    Luukkonen BG; Schwartz S
    Arch Virol; 1998; 143(7):1395-403. PubMed ID: 9722882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles.
    Lu YL; Bennett RP; Wills JW; Gorelick R; Ratner L
    J Virol; 1995 Nov; 69(11):6873-9. PubMed ID: 7474102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.
    Luukkonen BG; Fenyö EM; Schwartz S
    Virology; 1995 Feb; 206(2):854-65. PubMed ID: 7856098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
    Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging.
    Poon DT; Chertova EN; Ott DE
    Virology; 2002 Feb; 293(2):368-78. PubMed ID: 11886257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.
    Kondo E; Göttlinger HG
    J Virol; 1996 Jan; 70(1):159-64. PubMed ID: 8523520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.
    Damgaard CK; Dyhr-Mikkelsen H; Kjems J
    Nucleic Acids Res; 1998 Aug; 26(16):3667-76. PubMed ID: 9685481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.
    Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E
    J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
    Jenkins Y; Pornillos O; Rich RL; Myszka DG; Sundquist WI; Malim MH
    J Virol; 2001 Nov; 75(21):10537-42. PubMed ID: 11581428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro.
    Li MS; Garcia-Asua G; Bhattacharyya U; Mascagni P; Austen BM; Roberts MM
    Biochem Biophys Res Commun; 1996 Jan; 218(1):352-5. PubMed ID: 8573160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.